Prion disorders manifest when a normal cell surface glycoprotein, the prion protein (PrPC), undergoes a conformational change from an a-helical to a 13-sheet rich structure (PrPSc) that is pathogenic. Deposits of PrPSC in the brain parenchyma are considered the principal cause of neurotoxicity in prion disorders. In familial forms of these disorders, a point mutation in the prion protein gene (PRNP) is thought to mediate the conformational change of mutant PrP to PrPSc, resulting in pathogenicity. Despite the reported high co-relation between PrPSc deposits and clinical disease, neurodegeneration in prion disorders is often seen without detectable PrPS, indicating the presence of alternative mechanisms of cellular toxicity. Results from my laboratory show that in familial prion disorders, abnormal metabolism of the mutant prion protein leads to neuronal toxicity by distinct cellular pathways, unique to each mutation. The stop codon mutation at residue 145 (PrP145) leads to accumulation of PrP145 in the endoplasmic reticulum (ER) and in the nucleus, while the Q21 7R mutation (PrP217) causes accumulation of PrP217 in the ER and in the lysosomal compartment. The P102L mutation (PrP'?2), on the other hand, results in the accumulation of an amyloidogenic fragment of PrP'?2 on the cell surface. Based on these observations, we hypothesize that point mutations in different region(s) of PrP alter PrP metabolism and initiate neuronal death through distinct intracellular pathways unique to each mutation (or a group of mutations), and not by the common pathway of PrPSc accumulation. In this proposal, we will investigate this hypothesis by analyzing the biogenesis of mutant PrP with point mutations in three distinct regions of PrP: (1) the glycosylphosphatidyl inositol anchor signal peptide (GPI-SP) of PrP, (2) up to twenty-five amino acids upstream from the GPI addition site, and (3) in the vicinity of PrP glycosylation sites. ? ? We will use transfected human neuroblastoma cells to investigate the processing, transport, and turnover of wild type and mutant PrP using immunoprecipitation, Western blotting, and other cell and molecular biology techniques. Sub-cellular localization of PrP will be examined by confocal and electron microscopy. The results obtained will be confirmed in differentiated NT-2N cells and human embryonic neurons in culture. A C-terminal Flag-tagged PrP and a PrP-GFP construct developed in my laboratory will be used to complement the above methods. The Flag tag will allow specific identification of the GPI-SP, and the PrP-GFP construct will enable analysis of mutant PrP in living cells. This study will uncover alternative pathways of neuronal toxicity by mutant PrP besides conversion to PrPSc, and help in developing rational therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035962-08
Application #
6751599
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Nunn, Michael
Project Start
1997-02-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
8
Fiscal Year
2004
Total Cost
$290,700
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Brooks, Jada L; Holditch-Davis, Diane; Landerman, Lawrence R et al. (2011) Exploring modifiable risk factors for wheezing in African American premature infants. J Obstet Gynecol Neonatal Nurs 40:302-11
Singh, Ajay; Mohan, Maradumane L; Isaac, Alfred Orina et al. (2009) Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis. PLoS One 4:e4468
Singh, Ajay; Isaac, Alfred Orina; Luo, Xiu et al. (2009) Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog 5:e1000336
Holditch-Davis, Diane; Miles, Margaret Shandor; Weaver, Mark A et al. (2009) Patterns of distress in African-American mothers of preterm infants. J Dev Behav Pediatr 30:193-205
Singh, Ajay; Kong, Qingzhong; Luo, Xiu et al. (2009) Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport. PLoS One 4:e6115
Gu, Yaping; Singh, Ajay; Bose, Sharmila et al. (2008) Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells. Mol Cell Neurosci 37:647-56
Gu, Yaping; Verghese, Susamma; Bose, Sharmila et al. (2007) Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly'intracellular aggregates. J Mol Neurosci 32:90-6